National | FOCUS Feb 14, 2021
Some citizens remain skeptical as Japan gets set to roll out vaccines
In a survey conducted earlier this month, only 63.1% of people in Japan expressed willingness to get a shot while 27.4% said they were unwilling.
Some citizens remain skeptical as Japan gets set to roll out vaccines
In a survey conducted earlier this month, only 63.1% of people in Japan expressed willingness to get a shot while 27.4% said they were unwilling.
Japan is moving closer to vaccinations: Here's how the rollout will work
The government has begun to set out its inoculation schedule, but there are concerns over delivery hiccups.
As virus grows stealthier, vaccine makers reconsider battle plans
As the coronavirus assumes contagious new forms around the world, two drugmakers reported on Monday that their vaccines, while still effective, offer less protection against one variant and began revising plans to turn back an evolving pathogen that has killed more than 2 million ...
Japan scrambles to roll out vaccine, but how many people will get the shot?
Polls have shown recently that nearly 70% of Japanese are willing to get a coronavirus vaccine. But still, skepticism against vaccines is deeply rooted in the country.
mRNA vaccines could vanquish COVID-19 today, cancer tomorrow
Therein lies mRNA’s bigger promise: It can tell our cells to make whatever protein we want. That includes the antigens of many other diseases besides COVID-19.
Japanese approval of Moderna COVID-19 vaccine unlikely before May
Tokyo is facing a major regulatory bottleneck due to requirements for local clinical trials before requesting approval for coronavirus shots.
Astra-Oxford coronavirus vaccine gets its first clearance with U.K. approval
AstraZeneca PLC and the University of Oxford’s Covid-19 vaccine won U.K. clearance, marking the first approval worldwide for a shot that will be key to mass immunizations.
How vaccine-makers are preparing for mutant coronavirus strains
Drugmakers have said they could reset the COVID-19 shot to counter a new strain within just six weeks.
Vaccines alone aren’t enough to beat COVID-19
While an effective vaccine is sure to help, a safe oral antiviral drug would truly step up efforts to fight the pandemic.
Moderna to seek U.S. and EU clearance for COVID-19 vaccine
The move came after a new analysis showed the vaccine was highly effective in preventing COVID-19 with no serious safety problems.
Not so fast, Japan experts say, as COVID-19 vaccines raise hopes
Medical experts say long-term safety and efficacy concerns remain as the vaccines are developed in record-setting time.
Pfizer vaccine's safety milestone is just the beginning
As new vaccines look set for regulatory approval, managing the follow-up on adverse drug reactions will be critical for any vaccination program to be successful.